Skip to main content
Year archive

Camurus — 2016 filings

All 34 regulatory filings released by Camurus (CAMX) in 2016, sourced directly from the official regulator.

34 Filings
2016 Period
2016 filings (34)
Filing Released Lang
Camurus och Braeburn Pharmaceuticals tillkännager positiva fas 3-resultat för långtidsverkande buprenorfin (CAM2038) för behandling av opiatberoende
Regulatory Filings
2016-11-14 Swedish
Braeburn Pharmaceuticals and Camurus Announce Positive Top-line Phase 3 Results for Long-acting Buprenorphine for Treatment of Opioid Addiction
Earnings Release FY 2016
2016-11-14 English
Interim / Quarterly Report 2016
Interim / Quarterly Report 9M 2016
2016-11-08 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report 9M 2016
2016-11-08 English
Nomination Committee appointed in respect of AGM 2017 in Camurus
Board/Management Information
2016-10-28 English
Valberedning utsedd inför årsstämma 2017 i Camurus
Board/Management Information
2016-10-28 Swedish
Braeburn Pharmaceuticals and Camurus Expand Collaboration and License Agreement to include New Combination Product for Pain and Nausea
Regulatory Filings
2016-10-24 English
Camurus utvidgar samarbetet med Braeburn Pharmaceuticals med ny kombinationsprodukt mot smärta och illamående
Regulatory Filings
2016-10-24 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report H1 2016
2016-07-14 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report H1 2016
2016-07-14 English
Interim / Quarterly Report 2016
Interim / Quarterly Report Q1 2016
2016-05-17 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report Q1 2016
2016-05-17 English
Camurus och Braeburn Pharmaceuticals meddelar positiva resultat från en fas 2-studie av CAM2038 i opiatberoende patienter
Regulatory Filings
2016-05-11 Swedish
Braeburn Pharmaceuticals and Camurus announce positive results from Phase 2 opioid challenge study with CAM2038 in subjects with opioid use disorder
Regulatory Filings
2016-05-11 English
Beslut vid Camurus årsstämma 2016
AGM Information
2016-05-03 Swedish
Resolutions at the Annual General Meeting 2016 in Camurus
AGM Information
2016-05-03 English
Distribution agreement signed with R-PHARM US for episil®
Regulatory Filings
2016-04-21 English
Distributionsavtal tecknat med R-PHARM US för episil®
Regulatory Filings
2016-04-21 Swedish
Camurus och Braeburn Pharmaceuticals meddelar att rekryteringsmålen uppfyllts i två fas 3-studier av CAM2038 för behandling av opiatberoende
Regulatory Filings
2016-04-05 Swedish
Braeburn Pharmaceuticals and Camurus announce Enrollment goals reached in two pivotal Phase 3 Trials of CAM2038 for treatment of opioid dependence
Regulatory Filings
2016-04-05 English
Annual Report 2015
Annual Report FY 2015
2016-03-30 Swedish
Annual Report 2015
Annual Report FY 2015
2016-03-30 English
Kallelse till årsstämma 2016 och förslag om nytt incitamentsprogram i Camurus AB (publ)
AGM Information
2016-03-30 Swedish
Notice of annual general meeting 2016 and proposal for new incentive program in Camurus AB (publ)
AGM Information
2016-03-30 English
Camurus och Braeburn Pharmaceuticals startar fas 2-studie i opiatberoende patienter med kronisk smärta
Regulatory Filings
2016-02-22 Swedish
Braeburn and Camurus Announce Initiation of a Phase 2 Study in Opioid Dependent Patients with Moderate to Severe Chronic Pain
Regulatory Filings
2016-02-22 English
Earnings Release 2015
Earnings Release FY 2015
2016-02-17 Swedish
Annual Report 2015
Annual Report FY 2015
2016-02-17 English
Nomination Committee appointed in respect of AGM 2016 in Camurus
Board/Management Information
2016-02-04 English
Valberedning utsedd inför årsstämma 2016 i Camurus
Board/Management Information
2016-02-04 Swedish
Ändring av antalet aktier och röster i Camurus
Declaration of Voting Results & Voting Rights Announcements
2016-01-07 Swedish
Change in the number of shares and votes in Camurus
Declaration of Voting Results & Voting Rights Announcements
2016-01-07 English
Camurus och Rhythm annonserar licensavtal för långtidsverkande FluidCrystal setmelanotide
Regulatory Filings
2016-01-05 Swedish
Rhythm and Camurus Announce License Agreement for Extended Release FluidCrystal Setmelanotide
Regulatory Filings
2016-01-05 English